Can a diabetes drug help hearts heal better after a heart attack?

NCT ID NCT07469943

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at whether empagliflozin, a medicine used for diabetes, can help blood vessels and heart muscle recover after a heart attack. About 80 people who had a severe heart attack will either receive empagliflozin or standard care. Researchers will measure artery stiffness, blood vessel health, and heart function over 12 months to see if the drug makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
empagliflozin (a diabetes pill that also helps the heart)
What this could lead to
If it works, this could show that empagliflozin helps blood vessels and the heart recover better after a heart attack, potentially reducing future heart problems.
What could go wrong
This is a small, early-stage study with only 80 people, so results may not apply to everyone. It is not designed to prove that empagliflozin prevents death or major events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Attikon University Hospital, 2nd Department of Cardiology, National and Kapodistrina University of Athens

    RECRUITING

    Athens, Rimini1/Haidari, 12462, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.